Request a Demo Log In
Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V., Docket No. 21-01071 (Fed. Cir. Oct 20, 2020), Court Docket
X1Q6O7V6VE82
DOCKETS
Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V.

Search

Search over:

No Matches Found

Search term(s) not found.

Docket Entries Since Last Update
NOTE: This court's RSS feed does not list MOTION entries, so Bloomberg Law cannot detect them and thus they will not be listed here. However, motions will be included if you update the docket.

Copy with Citation

Copy the text below to paste into your document.

Link citations to Bloomberg Law
Court Dockets
cafc
U.S. Court of Appeals for the Federal Circuit
Docket for Case #: 21-1071

Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V.

DOCKET INFORMATION
Minimize
Date Filed: Oct 20, 2020
Status: Closed
Original Cases:
IPR2020-00440, United States Patent and Trademark Office
District: PTO
NOA Date: Oct 20, 2020

Parties and Attorneys

Expand AllMinimize
Expand All
Hide Section

 Appellant
MYLAN LABORATORIES LTD.
Appellant
Representation
Deepro Mukerjee
Katten Muchin Rosenman LLP
575 Madison Avenue
New York, NY 10022
Personal: (212) 940-8552
[LD NTC Retained]
Johnjerica Hodge, -
Katten Muchin Rosenman LLP
2900 K Street, NW
North Tower
Suite 200
Washington, DC 20007
Personal: 202-625-3710
[COR NTC Retained]
Jitendra Malik
Katten Muchin Rosenman LLP
550 South Tryon Street
Suite 2900
Charlotte, NC 28202
Personal: 704-344-3185
[COR NTC Retained]
Lance Soderstrom, Attorney
Katten Muchin Rosenman LLP
575 Madison Avenue
New York, NY 10022
[COR NTC Retained]
Eric Thomas Werlinger
Katten Muchin Rosenman LLP
2900 K Street, NW
North Tower
Suite 200
Washington, DC 20007
[COR NTC Retained]

 Appellee
JANSSEN PHARMACEUTICA, N.V.
Appellee
Representation
Pratik A. Shah, Attorney
Akin Gump Strauss Hauer & Feld LLP
2001 K Street NW
Washington, DC 20006
Personal: 202-887-4210
[LD NTC Retained]
Z.W. Julius Chen, Attorney
Akin Gump Strauss Hauer & Feld LLP
2001 K Street NW
Washington, DC 20006
Personal: 202-887-4475
[COR NTC Retained]
Andrew D. Cohen, -
Patterson Belknap Webb & Tyler LLP
1133 Avenue of the Americas
New York, NY 10036
Personal: 212-336-2000
[COR NTC Retained]
Barbara Mullin
Patterson Belknap Webb & Tyler LLP
1133 Avenue of the Americas
New York, NY 10036
Personal: 212-336-2000
[COR NTC Retained]
Ruben H. Munoz, Attorney
Akin Gump Strauss Hauer & Feld LLP
1735 Market Street
Philadelphia, PA 19103
Personal: 215-965-1263
[COR NTC Retained]

Intervenor
ANDREI IANCU, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office
Intervenor

 Intervenor
ANDREW HIRSHFELD, Performing the Functions and Duties of the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office
Intervenor
Representation
Michael S. Forman, Associate Solicitor
United States Patent and Trademark Office
PO Box 1450
Mail Stop 8
Alexandria, VA 22313
[LD NTC Government]
Mary L. Kelly, Associate Solicitor
United States Patent and Trademark Office
PO Box 1450
Mail Stop 8
Alexandria, VA 22313
[COR NTC Government]
Thomas W. Krause, Solicitor
United States Patent and Trademark Office
PO Box 1450
Mail Stop 8
Alexandria, VA 22313
Personal: 571-272-9035
[COR NTC Government]
Melissa N. Patterson, Attorney
Department of Justice
950 Pennsylvania Avenue NW
Washington, DC 20530
[COR NTC Government]
Farheena Yasmeen Rasheed, Acting Solicitor
United States Patent and Trademark Office
PO Box 1450
Mail Stop 8
Alexandria, VA 22313
[COR NTC Government]
Weili J. Shaw, Trial Attorney
DOJ-Civ
950 Pennsylvania Avenue NW
Washington, DC 20530
[COR NTC Government]
Molly R. Silfen, Associate Solicitor
United States Patent and Trademark Office
PO Box 1450
Mail Stop 8
Alexandria, VA 22313
[COR NTC Government]

Docket Entries

Reverse Entries
Hide Section
Print Entries Request Entries Reverse Entries

EntryFiledPDFDescription
BL-1Oct 20, 2020ViewAppeal docketed. Received: 10/20/2020. [730178] <br>Entry of Appearance is due on 11/03/2020. Certificate of Interest is due on 11/03/2020. Docketing Statement is due on 11/03/2020. Certified List is due on 11/30/2020. [EKD]
BL-2Nov 3, 2020RequestEntry of appearance for Pratik A. Shah; Z.W. Julius Chen; Ruben H. Munoz; Barbara L. Mullin; Andrew D. Cohen as counsel for Appellee Janssen Pharmaceutica, N.V.. Service: 11/03/2020 by email. [733432] [21-1071] [Pratik Shah]
BL-3Nov 3, 2020RequestCertificate of Interest for Appellee Janssen Pharmaceutica, N.V.. Service: 11/03/2020 by email. [733433] [21-1071] [Pratik Shah]
BL-4Nov 3, 2020RequestDocketing Statement for the Appellee Janssen Pharmaceutica, N.V.. Service: 11/03/2020 by email. [733434] [21-1071] [Pratik Shah]
BL-5Nov 3, 2020ViewDocketing Statement for the Appellant Mylan Laboratories Ltd.. Service: 11/03/2020 by email. [733439] [21-1071] [Deepro Mukerjee]
BL-6Nov 3, 2020RequestEntry of appearance for Deepro R. Mukerjee; Lance A. Soderstrom; Jitendra Malik; Eric Werlinger as counsel for Appellant Mylan Laboratories Ltd.. Service: 11/03/2020 by email. [733442] [21-1071] [Deepro Mukerjee]
BL-7Nov 3, 2020RequestCertificate of Interest for Appellant Mylan Laboratories Ltd.. Service: 11/03/2020 by email. [733443] [21-1071] [Deepro Mukerjee]
BL-8Nov 5, 2020ViewMOTION of Appellee Janssen Pharmaceutica, N.V. to terminate appeal through dismissal. Cases to be terminated: 21-1071. (Briefing suspended pursuant to FCR 31 pending resolution of the motion).. Service: 11/05/2020 by email. [734058] [21-1071] [Pratik Shah]
BL-9Nov 9, 2020ViewMOTION of Appellant Mylan Laboratories Ltd. to extend time. Service: 11/09/2020 by email. [734587] [21-1071] [Eric Werlinger]
BL-10Nov 13, 2020ViewORDER granting motion to extend time to file . Mylan's response to the motion to dismiss is due no later than December 7, 2020. Service as of this date by the Clerk of Court. [735452] [NL]
BL-11Nov 30, 2020RequestNotice from the United States Patent and Trademark Office of non-filing of the certified list. Service: 11/30/2020 by email. [738852] [EKD]
BL-12Dec 3, 2020RequestNotice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 12/03/2020 by email. [739935] [21-1071] [Michael Forman]
BL-13Dec 3, 2020RequestEntry of appearance for Michael S. Forman; Mary L. Kelly; Molly R. Silfen; Thomas W. Krause; Farheena Y. Rasheed as counsel for Intervenor, Director - U.S. Patent and Trademark Office. Service: 12/03/2020 by email. [739936] [21-1071] [Michael Forman]
BL-14Dec 7, 2020ViewRESPONSE from USPTO Director to the motion . Service: 12/07/2020 by email. [740776] [21-1071] [Michael Forman]
BL-15Dec 7, 2020RequestEntry of appearance for Johnjerica Hodge as counsel for Appellant Mylan Laboratories Ltd.. Service: 12/07/2020 by email. [740828] [21-1071] [Johnjerica Hodge]
BL-16Dec 7, 2020ViewRESPONSE of Appellant Mylan Laboratories Ltd. to the motion . Service: 12/07/2020 by email. [740923] [21-1071] [Eric Werlinger]
BL-17Dec 7, 2020ViewMOTION of Appellee Janssen Pharmaceutica, N.V. to extend time. Service: 12/07/2020 by email. [740926] [21-1071] [Pratik Shah]
BL-18Dec 8, 2020ViewORDER granting motion to extend time filed by Appellee Janssen Pharmaceutica, N.V. Janssen's reply in support of its motion to dismiss is due no later than December 21, 2020. Service as of this date by the Clerk of Court. [741102] [LMS]
BL-19Dec 21, 2020ViewREPLY of Appellee Janssen Pharmaceutica, N.V. to response . Service: 12/21/2020 by email. [744389] [21-1071] [Pratik Shah]
BL-20Jan 14, 2021ViewORDER filed granting the Director's motion to intervene. The revised official caption is reflected above. The Director is directed to file a docketing statement no later than 14 days from the date of filing of this order. Telephonic oral argument on the motion to dismiss is scheduled for Friday, February 12, 2021 at 10:00 a.m. Janssen, Mylan, and the Director will each be allotted fifteen minutes for argument. (Per Curiam). Service as of this date by the Clerk of Court. [749374] [LMS]
BL-21Jan 14, 2021RequestNOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2102N. Case scheduled February 12, 2021. Response to Notice of Oral Argument due: 01/21/2021. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found <a href="http://www.cafc.uscourts.gov/sites/default/files/rules-of-practice/forms/form33.pdf">here</a>. The Oral Argument Guide can be found <a href="http://www.cafc.uscourts.gov/sites/default/files/arguments/OralArgumentGuide.pdf">here</a>. Service as of this date by the Clerk of Court. [749605] [MJL]
BL-22Jan 15, 2021RequestClerk's letter to Appellant Mylan Laboratories Ltd., Appellee Janssen Pharmaceutica, N.V. and Intervenor Andrei Iancu regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [749810] [JAB]
BL-23Jan 21, 2021ViewResponse to notice of oral argument from Intervenor Andrei Iancu. Service: 01/21/2021 by email. [750401] [21-1071] [Michael Forman]
BL-24Jan 21, 2021ViewResponse to notice of oral argument from Appellee Janssen Pharmaceutica, N.V.. Service: 01/21/2021 by email. [750438] [21-1071] [Pratik Shah]
BL-25Jan 21, 2021ViewResponse to notice of oral argument from Appellant Mylan Laboratories Ltd.. Service: 01/21/2021 by email. [750657] [21-1071] [Deepro Mukerjee]
BL-26Jan 28, 2021RequestDocketing Statement for the Intervenor Andrei Iancu. Service: 01/28/2021 by email. [752305] [21-1071] [Michael Forman]
BL-27Jan 29, 2021ViewORDER filed. The parties and the United States should come to argument prepared to address the questions raised in this order (see attached). By: Per Curiam. Service as of this date by the Clerk of Court. [752881] [MJL]
BL-28Feb 2, 2021ViewEntry of appearance for Melissa N. Patterson; Weili J. Shaw as counsel for Intervenor Andrei Iancu. Service: 02/02/2021 by email. [753373] [21-1071] [Melissa Patterson]
BL-29Feb 2, 2021ViewAmended Response to notice of oral argument from Intervenor Andrei Iancu. Service: 02/02/2021 by email. [753374] [21-1071] [Melissa Patterson]
BL-30Feb 11, 2021RequestOfficial caption revised to reflect Andrew Hirshfeld as Performing the Functions and Duties of the Under Secretary of Commerce for Intellectual Property and Director of the USPTO. (see attached). Service as of this date by the Clerk of Court. [755563] [MJL]
BL-31Feb 12, 2021RequestSubmitted after ORAL ARGUMENT on Appellee's Motion to Dismiss to Panel: Newman, Circuit Judge; Moore, Circuit Judge and Stoll, Circuit Judge.<br>Arguing counsel: Deepro Mukerjee for Mylan Laboratories Ltd., Mr. Pratik A. Shah for Janssen Pharmaceutica, N.V. and Melissa N. Patterson for Andrew Hirshfeld.<br>Oral Argument Audio available <a href="http://oralarguments.cafc.uscourts.gov/default.aspx?fl=21-1071_02122021.mp3">here</a>. [755787] [JCP]
BL-32Mar 12, 2021ViewPRECEDENTIAL ORDER filed. Janssen's motion to dismiss is granted. Mylan's petition for a writ of mandamus is denied. Costs are awarded to Janssen. By: Motions Panel. Service as of this date by the Clerk of Court. [761791] [MJL]
BL-33May 3, 2021RequestMandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [772445] [MVH]
BL-34Aug 13, 2021RequestPetition for writ of certiorari filed on 08/09/2021 in the U.S. Supreme Court. No.: 21-202, Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V. [793607] [MJL]
BL-35Jan 18, 2022RequestThe petition for writ of certiorari, No. 21-202, filed on 08/09/2021, was Denied on 01/18/2022. [825660] [MVH]

Jump To
Please enter a valid page number
Pagination
Show Pagination
 

back to top

Enter a Client Matter

Your firm optionally allows a client matter to be selected while you are using Bloomberg Law. Please contact your administrator if you have any questions. Please select from a recently used Client Matter or enter a Client Matter manually.
RECENTLY USED
CLIENT MATTER
Please contact your administrator if you have questions about client matter.
Cancel Submit
Unrecognized Client Matter

Client Matter   does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
Bloomberg Industry Group
About Us Contact Us
Other Products
Big Law Business Professional Learning BNA
Help Topics
Getting Started BCite Citator Smart Code Points of Law Browse All Help Topics
24/7 BLAW® Help Desk
888.560.2529
help@bloomberglaw.com
0.1438.0
Terms of Service Privacy Policy Copyright Accessibility
© 2022 The Bureau of National Affairs, Inc. All Rights Reserved.